Welcome to our dedicated page for HARTE HANKS SEC filings (Ticker: HHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HARTE HANKS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HARTE HANKS's regulatory disclosures and financial reporting.
HARTE HANKS INC (HHS) received an updated Schedule 13D/A from stockholder Bradley L. Radoff, who reports beneficial ownership of 423,447 common shares, representing 5.7% of the 7,454,240 shares outstanding as of July 31, 2026. Most of his stake (368,900 shares) was bought with personal funds for an aggregate purchase price of about $1,958,836, and he also holds 82,408 RSUs granted as a director, of which 54,547 have vested.
The filing describes a planned merger under an Agreement and Plan of Merger among Harte Hanks, Star Equity Holdings, Inc., and Merger Sub - R, Inc. Each outstanding Harte Hanks share (other than certain excluded shares) is to be converted into the right to receive either $5.00 in cash per share, 0.50 share of Star 10% Series A Cumulative Perpetual Preferred Stock per share, or a combination, subject to stockholder elections and Merger Agreement terms. Radoff entered into a Voting and Support Agreement requiring him to vote all his shares in favor of the merger proposal and against alternative transactions, with customary lock-up restrictions in place until the merger closes or the agreement otherwise terminates. The filing notes that he has made no transactions in Harte Hanks securities during the past 60 days.
HARTE HANKS INC (HHS) received Amendment No. 9 to a Schedule 13G from Westerly Capital Management, LLC and related reporting persons. The filing states that they now beneficially own 0 shares of Harte Hanks common stock, representing 0.0% of the class, with no sole or shared voting or dispositive power.
Harte Hanks, Inc. (HHS) entered into a definitive Agreement and Plan of Merger with Star Equity Holdings, Inc., under which a Star subsidiary will merge into Harte Hanks and Harte Hanks will become a wholly owned subsidiary of Star.
Each Harte Hanks share (other than treasury and Star-held shares) will be converted into either $5.00 in cash or 0.50 share of Star’s 10% Series A Cumulative Perpetual Preferred Stock, or a mix, with total cash (including cash in lieu of fractional preferred shares) capped at $19.2 million. No fractional preferred shares will be issued; fractions will be cashed out at $10.00 per preferred share. Vested options and RSUs are cashed out or paid in preferred stock based on this merger consideration, while unvested options, unvested RSUs that do not vest at closing, and all performance stock units are cancelled without payment.
The merger requires Harte Hanks stockholder approval, effectiveness of a Star Form S‑4 registration statement, completion of up to $15 million in debt financing (or alternative financing), third‑party consents, and other customary conditions. A 30‑day go‑shop allows Harte Hanks to solicit superior proposals. Directors and certain officers signed voting and support agreements. Mutual termination fees and liability caps of $1,152,000 apply to each party in specified scenarios.
Harte Hanks, Inc. reported weaker results for the quarter and six months ended June 30, 2026 and disclosed a pending sale to Star Equity Holdings. Quarterly revenue was $37.98 million, down 1.7% year over year, and the company posted an operating loss of $4.49 million versus near break-even in 2025. Net loss widened to $5.00 million (basic and diluted EPS $(0.67)) from a loss of $0.34 million (EPS $(0.05)). For the first half of 2026, revenue declined 6.2% to $75.25 million, with an operating loss of $5.26 million compared with essentially break-even a year earlier; net loss increased to $5.63 million (EPS $(0.76)) from $0.73 million.
Cash and restricted cash were $5.19 million, and Harte Hanks used $2.65 million in operating cash in the first half, an improvement from $5.67 million used a year earlier. The company had $3.0 million drawn on its $25.0 million asset-based revolving credit facility and available borrowing capacity of $21.3 million. Total stockholders’ equity declined to $15.35 million from $20.53 million at year-end 2025.
Subsequent to quarter end, Harte Hanks entered into a merger agreement under which Star Equity agreed to acquire all outstanding shares in a stock-and-cash transaction. Each Harte Hanks share will be converted into the right to receive $5.00 in cash or equivalent Star Equity preferred stock, subject to a 50% cap on aggregate cash consideration. The estimated total consideration is approximately 1.92 million preferred shares and $19.2 million in cash, with closing targeted for the fourth quarter of 2026, subject to stockholder approval and other conditions.
HARTE HANKS INC President David Scott Fisher reported routine equity compensation activity and related tax withholding. Restricted stock units vested and were converted from indirectly held awards into 18,790 directly owned common shares at a reference price of $2.62 per share, while 7,876 shares were withheld to cover tax obligations tied to this vesting. Following these transactions, Fisher also holds 53,334 restricted stock units indirectly through Harte Hanks until they vest. In addition, he retains nonqualified stock options indirectly covering 32,300, 32,400 and 32,400 underlying common shares at exercise prices of $7.74, $4.55 and $5.34 per share, with expiration dates in 2034 and 2035. Overall, the filing reflects compensation-related vesting, tax withholding, and continued equity-based incentives rather than open-market buying or selling.
Harte Hanks, Inc. reported results of its 2026 annual meeting of stockholders. Stockholders elected four director nominees, with support levels generally around 5.0 million votes "for" and approximately 0.2 million "withheld," plus 394,667 broker non-votes for each nominee.
Stockholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 4,875,115 votes for, 246,517 against, 1,536 abstentions, and 394,667 broker non-votes. In addition, they ratified the selection of Wolf & Company P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 5,506,650 votes for, 7,581 against and 3,604 abstentions.
Harte Hanks, Inc. reported softer results for the quarter ended March 31, 2026. Revenue was $37.3 million, down 10.3% from $41.6 million, driven mainly by a 16.6% decline in Fulfillment & Logistics and a 9.9% drop in Revenue Solutions, while Customer Care slipped 1.1%.
Operating expenses fell 8.6% to $38.0 million, but the company still posted an operating loss of $0.8 million versus a near breakeven loss a year earlier. Net loss widened to $0.6 million, or $(0.08) per share, compared with a $(0.05) loss.
Harte Hanks continued its "Project Elevate" restructuring, recording $0.2 million of charges in the quarter and $10.0 million cumulatively through March 31, 2026. Cash and restricted cash totaled $4.5 million, with no borrowings and $24.3 million available under its revolving credit facility, supporting liquidity despite modest cash use in operations.
Harte Hanks, Inc. reported first quarter 2026 results showing lower revenue and earnings while maintaining a debt-free balance sheet. Revenue was $37.3 million, down 10.3% from $41.6 million a year earlier, as legacy offerings and market headwinds weighed on sales. Operating loss widened to $0.8 million from a loss of $0.04 million, and net loss increased to $0.6 million, or $0.08 per share, compared with $0.4 million, or $0.05 per share. EBITDA declined to $0.3 million from $1.0 million, and Adjusted EBITDA fell to $0.7 million from $1.8 million, reflecting higher pressure on profitability despite restructuring. Segment revenue decreased across Customer Care, Fulfillment & Logistics, and Revenue Solutions, with notable declines in Fulfillment & Logistics. The company ended the quarter with $4.5 million in cash, no debt, and $24.3 million of available credit capacity, and management continues to emphasize a sector-aligned growth strategy targeting positive EBITDA for 2026.
Harte Hanks, Inc. is asking stockholders to vote at a virtual annual meeting on May 21, 2026 to elect four directors, approve executive pay on an advisory basis, and ratify Wolf & Company P.C. as auditor for 2026.
The company highlights 2025 as a turning point, ending the year with $5.6 million in free cash, no outstanding debt, and an amended credit facility providing $24 million of availability. Net loss per share improved from $4.15 in 2024 to $0.11 in 2025, and the last quarter produced $2.2 million of net income versus a $2.4 million loss in the comparable 2024 quarter.
Management describes a multi‑year “stabilize, streamline, and scale” program, including cost reductions under Project Elevate and new customer-care engagements such as a Greenville, South Carolina facility anchored by Samsung Electronics America. Priorities for 2026 include deepening customer relationships, strengthening sales execution, and expanding use of AI and modernized facilities across Fulfillment & Logistics, Marketing Services, and Customer Care.
Harte Hanks, Inc. reported fourth-quarter 2025 and full-year 2025 results showing lower revenue but improved bottom-line metrics. Q4 revenue was $39.9 million, down 15.4% from $47.1 million a year earlier, yet net income swung to $2.2 million, or $0.30 per share, from a $2.4 million loss.
For full year 2025, revenue declined to $159.6 million, down 13.9% from $185.2 million in 2024, and operating income fell to $0.4 million from $2.1 million. Even so, net loss narrowed sharply to $0.8 million from $30.3 million, as the prior year included $37.5 million of pension plan termination charges.
EBITDA for 2025 was $4.9 million versus $6.5 million in 2024, while Adjusted EBITDA declined to $6.9 million from $14.0 million, reflecting softer performance across segments. The company ended 2025 with $5.6 million in cash, no debt, and $24.0 million of credit line capacity, emphasizing continued focus on margin expansion and disciplined capital allocation.